Beacon Pharmaceuticals Limited posted an 8.3 per cent higher profit at Tk 93.56 crore in the financial year that ended on June 30.

The pharmaceutical company made a profit of Tk 86.39 crore in the previous year.

Thus, Beacon Pharmaceuticals reported earnings per share of Tk 4.05 for 2021-22. It was Tk 3.74 in 2020-21.

The net asset value per share of the company improved to Tk 25.73 in 2021-22 from Tk 23.18 a year earlier and the net operating cash flow per share surged to Tk 4.68 from Tk 0.85 a year earlier.

The board of directors has recommended a 16 per cent cash dividend for 2021-22.